Why would you think Brilacidin's safety would be an issue in this trial when it has not been a significant problem in any previous trial?
Imagine your mom presents to the hospital with an oxygen level of 88; respirations 28 a minute. Her doctor just told you her Covid swab was positive. He stated a new medicine was approved for Covid 19 which has been shown to reduce mortality and complications, but it may cause transient tingling and BP elevations?
News 
Market Data 
Discover 
